Model 7600 Regional Oximeter System
Contents
1. ajira haa Nonin Medical Innovative Leaders in Noninvasive Physiological Monitoring Nonin Medical is a technology driven company and a global leader in developing noninvasive medical monitoring solutions that improve the quality of people s lives and enable them to live their lives to the fullest We do this by developing low cost high quality easy to use technologies that empower clinicians to make better decisions and individuals to proactively manage their health References Cardiac Study on file at Nonin Medical viWolman RL et al Stroke 1999 30 514 Nonin Medical Inc Repeatability Study on file at Nonin Medical kMibrandt EB et al Crit Care Med 2008 Sep 36 2504 13700 1st Avenue North Exercise Comparison Study on file at Nonin Medical Dasta JF Crit Care Med 2005 Jun 33 1266 Plymouth MN 55441 5443 USA y i i i i Gol M I ioth Vasc A h2 10 171 Cardiovascular Surgery Study on file at Nonin Medical oe dman SM et al Sem Cardiothorac Vasc Anesth 2006 10 P 1 763 553 9968 TF 800 356 8874 Murkin JM et al Anesth Analg 2007 104 51 Salazar JD et al Ann Thorac Surg 2001 72 1195 Fischer Gregory W Recent Advances in Application of Cohn T The Cost of Biomedical Repair and Maintenance Results F 1 763 577 5521 E info nonin com Cerebral Oximetry in Adult Cardiovascular Surgery Seminars in of a Survey Med Instrum 1982 Sep Oct 16 5 269 71 Cardiothoracic and Vascular Anesthesia March 2008 i speach Flee2. i X QATR1587 Calibration and Validation of the Non Invasive z viChen PhD B FORE SIGHT Cerebral Oximetry Clinical Data Regional Oximeter System www noninequanox com Presentation DHCA Study Mount Sinai Medical Center Cerebral Oximetry Monitoring of Patients Undergoing Elective Thoracic Aortic Surgery with DHCA and SCP 15 Subjects September 2008 Data on file at Nonin Medical Inc Plymouth MN 2011 Nonin Medical Inc All trademarks are the property of Nonin Medical Inc unless otherwise noted INVOS System is a registered trademark of Somanetics Corporation FORE SIGHT is a registered trademark of CAS Medical Systems Inc hi w InSpectra is a registered trademark of Hutchinson Technology Incorporated EQUANOX Bluetooth C ors coe Se 8095 001 01 Nonin Medical AB Fibervagen 2 82450 Hudiksvall Sweden P 46 650 401500 F 46 650 401514 E infointl nonin se ORUPE Model 7600 Regional Oximeter System See the Difference medizintechnik Connect Medizintechnik GmbH spanngasse 4 A 2130 Mistelbach Tel 43 664 168 68 08 Fax 43 2572 20404 Improved patient outcomes A direct correlation to significantly ZOS EQUANOX Classic Sensor rSO During Open Heart Cardiac Bypass Surgery Stable and Responsive Measure of Patient Status 06 OOF OLL OL 09 OS OF 2 07 19 PM Baseline prior to induction Intubation complete 2 56 35 PM Channel Ao
3. CPU Maintenance Fuses Fan Cleanings Annual required maintenance No periodic maintenance ee required Battery Replacement i Battery Replacement i estimated 7 4 of acquisition cost estimated 7 4 of acquisition cost Weekly cleanings No Yes Yes Warranty Comparisons Monitor warranty 3 years 12 months 12 months EQUANOX Model 7600 User s Manual For use with the Model 8004CA Sensor Only 13 14 Nonin Medical The INVeENtOF of Fingertip Pulse Oximetry Nonin Medical Inc invented fingertip pulse oximetry with its introduction of the Onyx 9500 With 25 years of signal processing and sensor design expertise using near infrared spectroscopy NIRS Nonin s pulse oximetry and regional oximetry systems enable clinicians to quickly and accurately monitor patients in the widest range of settings even in the presence of low perfusion motion and other challenging conditions The Onyx Il Model 9560 is the world s first Continua certified fingertip pulse oximeter with Bluetooth wireless technology Nonin Medical was founded in 1986 by four engineers who launched the company from a basement One of those engineers Philip Isaacson is Nonin s Chief Technology Officer today Nonin Medical Founder and Chief Technology Officer Philip Isaacson Nonin Medical derives its name from the founders commitment to developing noninvasive physiological monitoring solutions that simplify he
4. althcare delivery reduce costs and enable people to live their lives to the fullest and an INNOVatoOTr in NIRS based Signal Processing The company s clinically proven PureSAT technology which provides signal processing speed stability and the ability to uniquely filter out artifact interference provides confidence to millions of clinicians worldwide and remains the hallmark of a Nonin oximeter today Nonin Medical s Onyx II Model 9560 fingertip pulse oximeter with Bluetooth wireless technology circled above monitors the vital signs of miner Jorge Galleguillos during his dramatic rescue from a collapsed Chilean copper mine Nonin Medical invented the world s frist fingertip and wireless fingertip pulse oximeters Photo Courtesy of CNN 15
5. inaccurately In the histograms A and B at left conventional trending technology is in graph A and EQUANOX Advance is in graph B Graph B represents the general alignment of data observations of both EQUANOX Advance reported rSO values blue and invasive blood draw derived SavO values orange at room air Available options Actual size 305 mm 12 0 W x 180 mm 7 2 Hx 130 mm 5 0 D FOUN 7600 _ pen Oximetry Pod EQUANOX Classic DB9 connector trending three wavelength sensor Display Monitor Trunk Cable Displays up to 4 channels Choice of 1 channel of rSO measurement 2 channel or 4 channel Oximetry Pod EQUANOX Advance 12 mini connector absolute four wavelength sensor See the difference Channels and Wavelengths Max Channels Wavelengths Monitor Specifics Weight 2 Ibs 900 g 14 Ibs 6 85 kg 14 Ibs 6 85 kg Battery life 3 hour 20 minutes 1 5 hour Battery designs Lithium ion Lead acid Lead acid Battery re charge times 2 5 hours 24 hours 16 5 hours Instant reading Yes ja Ne requires signal strength detection requires setup before sensor reading Operational Parameters Range of Sp0 0 100 15 95 0 99 Refresh rate 1 5 seconds 5 6 seconds 2 seconds Sensor Specifics Cerebral indications Trending Absolute Trending only Absolute Somatic indications Yes Yes Yes Tolerant to ambient light Yes No No Maintenance ie Fuses
6. ine EQUANOX Classic Sensor Model 8000CA with DB9 connector Hypoxia then a clinician may consider Zone intervention justified E Adequate Perfusion E Limited O Reserves Cerebral patient monitoring using EQUANOX Advance Sensor rSO readings with the four wavelength line rSO Clinical Range 0 My 3 4 100 60 rSO E i gt EQUANOX Advance Sensor Potential for limited oxygen reserves Adequate perfusion Model 8004CA with mini connector e Absolute rSO j is a reliable indicator of available oxygen reserves e Healthy patients have a resting baseline rSO of 60 or higher e If rSO falls below 60 percent a patient is potentially functioning with limited oxygen reserves at this point a clinician may consider intervention justified 10 Percent of Observations in Each Decade The best just got better Percent of Total Patients Conventional NIRS Trending Variability 50 40 30 20 20 40 60 80 100 rSO Values EQUANOX Advance rSO Values Aligned with Savo 70 70 60 70 70 80 80 90 Date rounded up percentages add up to greater than 100 rSO and SavO Decades Compared to traditional NIRS trending technology EQUANOX Advance is absolute providing enhanced accuracy in rSO measurements on all patients regardless of weight or skin color no more guessing or over treatment if patients do not read or read
7. ndustry leading accurate rSO measurements throughout the peri operative The powerful simple design of Nonin EQUANOX technology generates stable responsive signal processing to inspire confidence that rSO values reflect true Communications circuitry reliably sends secure digital data to the monitor and consistently accurate measurements you can rely on isolates patient for safety period Advanced signal processing and superior patient physiology sensor architecture eliminates interference for e Improved Outcomes Detect dangerous drops in regional oxygenation as they happen Dependable readings immediately alert the clinical team to a potential need for intervention Shielded circuitry avoids environmental interference to ensure stability Analog circuitry amplifies and refines sensor signals e Time Saving Reliability With proven repeatability of 2 digits there is no need to capture a new baseline after sensors have been moved or changed resulting in maximum Digital microcontroller with advanced signal processing provides lightning fast response convenience and time savings Choose from the EQUANOX Classic three wavelength sensor or the EQUANOX Advance tour wavelength sensor Cerebral patient monitoring using EQUANOX Classic Sensor rSO readings with the three wavelength line rSO Clinical Range 25 of Resting Baseline If rSO saturation falls 25 percent below basel
8. ne Emitter Two Receivers Examples include Hutchinson Technology InSpectra Examples include CASMED FORE SIGHT and Somanetics INVOS Light Detection Light Source Light Source 3 Third Generation Two Emitters Two Receivers Nonin HEQUANOX EQUANOX Technology Used in Cerebral Applications Unique to the EQUANOX technology dual emitters alternately create pairs of reflected light paths through surface tissue to the shallow receiver and through the cerebral cortex to the far receiver The system algorithm first uses the dual emitter architecture to remove surface effects that modulate light amplitude and then uses the shallow path to remove the surface tissue components from the deep path signals resulting in a cerebral cortex measurement that is unaffected by intervening tissue or surface effects It starts with EQUANOX sensor technology Ambient light tolerance No need to cover the sensor with shields Thin cables with optimized placement Thin cables attached at the center of the sensor make it easy to place sensors evenly Pliable foam material Prevents sensor lifting for maximized performance Interference tolerant Shielded for use in a wide variety of settings Accurate ina wide range of patients in a wide range of settings Proven Accuracy for Appropriate Clinical Action For real time cerebral injury protection the EQUANOX 7600 System delivers stable i
9. rtic cannulations 2 45 52 PM Initiation of cpb Time 4 35 05 PM 5 24 26 PM 6 13 43 PM EQUANOX Cerebral Injury Protection Results in Improved Outcomes and Reduced Costs According to multi disciplinary research the annual cost of Type 1 and Type 2 cerebral injury for a hospital completing 500 open heart cases per year can reach over 10 000 000 Studies show that noninvasive near infrared technology NIRS is highly effective in detecting cerebral oxygen deficiencies Stroke alone can be reduced 50 75 resulting in significant savings on treatment costs Protect Your Patients and Facility from Costly Peri Operative Cerebral Injury Continuous cerebral oxygenation monitoring throughout the peri operative cardiac surgery period is proven to reduce the rate of stroke reduced costs m icu 44 640 20 600 910 476 15 450 Type Type II The cost to treat a severe Type cerebral injury patient left and a Type II patient right are shown in the above chart Note The cost to treat a stroke patient increases substantially if ventilation is required Type of cerebral oxygen saturation rSO interventions in the intervention group Raise Pump Flow Raise MAP Normalize PaCo Deepen Anesthesia Increase Pulsatile FiO2 Perfusion Consistency Nonin Medical superior signal processing 1 First Generation 2 Second Generation One Emitter One Receiver O
Download Pdf Manuals
Related Search